Sendero Wealth Management, LLC Neurocrine Biosciences Inc Transaction History
Sendero Wealth Management, LLC
- $627 Million
- Q4 2024
A detailed history of Sendero Wealth Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Sendero Wealth Management, LLC holds 20,944 shares of NBIX stock, worth $2.49 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
20,944
Previous 20,272
3.31%
Holding current value
$2.49 Million
Previous $2.33 Million
22.5%
% of portfolio
0.46%
Previous 0.38%
Shares
13 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.21 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$583 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$359 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$302 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...